Literature DB >> 20473308

The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.

Karin Loser1, Thomas Vogl, Maik Voskort, Aloys Lueken, Verena Kupas, Wolfgang Nacken, Lars Klenner, Annegret Kuhn, Dirk Foell, Lydia Sorokin, Thomas A Luger, Johannes Roth, Stefan Beissert.   

Abstract

Mechanisms linking innate immunity and autoimmune responses are poorly understood. Myeloid-related protein-8 (Mrp8) and Mrp14 are damage-associated molecular pattern molecules (DAMPs) highly upregulated in various autoimmune disorders. We show in a mouse autoimmune model that local Mrp8 and Mrp14 production is essential for the induction of autoreactive CD8+ T cells and the development of systemic autoimmunity. This effect is mediated via Toll-like receptor 4 (TLR4) signaling leading to increased interleukin-17 (IL-17) expression. Notably, expression of Mrp8 and Mrp14 was upregulated in cutaneous lupus erythematosus, and stimulation of CD8+ T cells from individuals with lupus erythematosus with MRP proteins resulted in an upregulation of IL-17, suggesting a key role for MRP8 and MRP14 for the development of autoreactive lymphocytes during human autoimmunity as well. These results demonstrate a link between local expression of DAMP molecules and the development of systemic autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473308     DOI: 10.1038/nm.2150

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  29 in total

1.  Two-step negative enrichment of CD4+ and CD8+ T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail.

Authors:  M Gunzer; C Weishaupt; L Planelles; S Grabbe
Journal:  J Immunol Methods       Date:  2001-12-01       Impact factor: 2.303

2.  Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells.

Authors:  Dorothee Viemann; Anke Strey; Annette Janning; Kerstin Jurk; Kerstin Klimmek; Thomas Vogl; Keiichi Hirono; Fukiko Ichida; Dirk Foell; Beate Kehrel; Volker Gerke; Clemens Sorg; Johannes Roth
Journal:  Blood       Date:  2004-12-14       Impact factor: 22.113

3.  Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.

Authors:  Karin Loser; Annette Mehling; Stefanie Loeser; Jenny Apelt; Annegret Kuhn; Stephan Grabbe; Thomas Schwarz; Josef M Penninger; Stefan Beissert
Journal:  Nat Med       Date:  2006-12-03       Impact factor: 53.440

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Functional CD40 ligand is expressed by T cells in rheumatoid arthritis.

Authors:  K P MacDonald; Y Nishioka; P E Lipsky; R Thomas
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 6.  The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Authors:  Jan M Ehrchen; Cord Sunderkötter; Dirk Foell; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

7.  Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells.

Authors:  Fuping Zhang; Guangxun Meng; Warren Strober
Journal:  Nat Immunol       Date:  2008-10-12       Impact factor: 25.606

8.  Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

Authors:  I S Grewal; H G Foellmer; K D Grewal; J Xu; F Hardardottir; J L Baron; C A Janeway; R A Flavell
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.

Authors:  P L E M van Lent; L Grevers; A B Blom; A Sloetjes; J S Mort; T Vogl; W Nacken; W B van den Berg; J Roth
Journal:  Ann Rheum Dis       Date:  2007-11-30       Impact factor: 19.103

10.  The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.

Authors:  Marzia Caproni; Daniele Torchia; Emiliano Antiga; Barbara Giomi; Michele Mercuri; Walter Volpi; Paolo Fabbri
Journal:  J Rheumatol       Date:  2007-11-15       Impact factor: 4.666

View more
  120 in total

Review 1.  S100 proteins in cartilage: role in arthritis.

Authors:  Raghunatha R Yammani
Journal:  Biochim Biophys Acta       Date:  2012-01-12

2.  In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles.

Authors:  Andrei Maiseyeu; Marcus A Badgeley; Thomas Kampfrath; Georgeta Mihai; Jeffrey A Deiuliis; Cuiqing Liu; Qinghua Sun; Sampath Parthasarathy; Daniel I Simon; Kevin Croce; Sanjay Rajagopalan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-02       Impact factor: 8.311

Review 3.  [Translational research in pediatric rheumatology. Current research approaches to the innate immune system].

Authors:  K Lippitz; J Waldkirch; C Kessel; G Varga; D Foell
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

4.  Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.

Authors:  Felix Ratjen; Lisa Saiman; Nicole Mayer-Hamblett; Larry C Lands; Margaret Kloster; Valeria Thompson; Peggy Emmett; Bruce Marshall; Frank Accurso; Scott Sagel; Michael Anstead
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

5.  Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-γ- or IL-17-producing γδ T cells upon infection.

Authors:  Miguel Chaves-Ferreira; Francisco d'Orey; Julie C Ribot; Mélanie Wencker; Natacha Gonçalves-Sousa; Jérémie Decalf; João P Simas; Adrian C Hayday; Bruno Silva-Santos
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 6.  Novel Treatments in Lupus.

Authors:  Vasileios C Kyttaris
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

7.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

8.  Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens.

Authors:  Steven M Damo; Thomas E Kehl-Fie; Norie Sugitani; Marilyn E Holt; Subodh Rathi; Wesley J Murphy; Yaofang Zhang; Christine Betz; Laura Hench; Günter Fritz; Eric P Skaar; Walter J Chazin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 9.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

10.  S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.

Authors:  Radha Gopal; Leticia Monin; Diana Torres; Samantha Slight; Smriti Mehra; Kyle C McKenna; Beth A Fallert Junecko; Todd A Reinhart; Jay Kolls; Renata Báez-Saldaña; Alfredo Cruz-Lagunas; Tatiana S Rodríguez-Reyna; Nathella Pavan Kumar; Phillipe Tessier; Johannes Roth; Moisés Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Bridgette Cumming; Victoria O Kasprowicz; Adrie J C Steyn; Subash Babu; Deepak Kaushal; Joaquín Zúñiga; Thomas Vogl; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.